Home›Companies›Healthcare›Bainbridge Health

Bainbridge Health, Inc.

Updated Oct 27, 2026·Latest SEC filing May 8, 2025·Suggest an edit

About Bainbridge Health

Bainbridge Health is a private company based in Philadelphia, Pennsylvania. It has reported $9,300,001 raised in four offerings on Form D since March 2017. Its chief executive is Joseph Kaupp.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Apr 23, 2025May 8, 2025$3,400,001of $5.0M target6$566KEquityRule 506(b)Form D ↗
Sep 2, 2022Sep 29, 2022$3,350,000of $3.8M target4$837KEquityRule 506(b)Form D ↗
May 25, 2018Jun 7, 2018$1,250,000of $2.5M target3$416KEquityRule 506(b)Form D ↗
Mar 15, 2017Mar 24, 2017$1,300,000of $2.0M target4$325KEquityRule 506(b)Form D ↗
Total, four offerings$9,300,001

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Bainbridge Health's Form D filed May 8, 2025.

JK
Joseph Kaupp
CEO and director
SN
Sean O'Neill
Executive officer and director
AG
SH
TL
Thomas Lynch
Director

Earlier filings also listed Thomas Todorow (director, last listed Jun 2018), Steven Powell (director, last listed Jun 2018), Sam Wilson (executive officer, last listed Jun 2018) and Patrick Fitzgerald (director, last listed Mar 2017).

Sources

  1. SECBainbridge Health, Inc. filing history